Washington Trust Bank Gilead Sciences, Inc. Transaction History

Washington Trust Bank

$1.04 Billion
Q1 2024

A detailed history of Washington Trust Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Washington Trust Bank holds 3,359 shares of GILD stock, worth $243,729. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,359

Previous 3,419 1.75%

Holding current value

$243,729

Previous $276,000 10.87%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $4,294 - $5,237	-60 Reduced 1.75%	3,359 $246,000
Q3 2023 Nov 06, 2023	SELL	$73.94 - $80.67 $54,493 - $59,453	-737 Reduced 17.73%	3,419 $256,000
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $60,808 - $69,360	800 Added 23.84%	4,156 $320,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $28,991 - $33,030	-375 Reduced 10.05%	3,356 $278,000
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $232,515 - $333,812	3,731 New	3,731 $321,000

Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $218,239 - $245,802	-3,781 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $637 - $798	-11 Reduced 0.29%	3,781 $225,000
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $226,755 - $257,371	-3,495 Reduced 47.96%	3,792 $275,000
Q3 2021 Oct 27, 2021	BUY	$67.69 - $73.03 $232,650 - $251,004	3,437 Added 89.27%	7,287 $509,000
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $6,029 - $6,588	-95 Reduced 2.41%	3,850 $265,000
Q1 2021 Apr 22, 2021	BUY	$60.0 - $68.46 $236,700 - $270,074	3,945 New	3,945 $255,000
Q2 2019 Jul 26, 2019	SELL	$61.87 - $69.38 $135,557 - $152,011	-2,191 Closed	0 $0
Q1 2019 Apr 09, 2019	SELL	$62.53 - $70.05 $15,945 - $17,862	-255 Reduced 10.43%	2,191 $142,000
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $8,293 - $10,823	137 Added 5.93%	2,446 $153,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $73,418 - $81,287	1,030 Added 80.53%	2,309 $179,000
Q2 2018 Jul 03, 2018	SELL	$64.88 - $75.68 $9,732 - $11,352	-150 Reduced 10.5%	1,279 $90,000
Q1 2018 Apr 03, 2018	BUY	$72.84 - $88.8 $6,628 - $8,080	91 Added 6.8%	1,429 $108,000
Q4 2017 Jan 03, 2018	SELL	$71.15 - $83.52 $10,743 - $12,611	-151 Reduced 10.14%	1,338 $95,000
Q3 2017 Oct 05, 2017	BUY	$72.11 - $85.47 $107,371 - $127,264	1,489	1,489 $121,000

Others Institutions Holding GILD

# of Institutions

1,892

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $90.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Bank with notifications on news.

Account

Washington Trust Bank Gilead Sciences, Inc. Transaction History